1. Catalog
  2. GROVIOEM2503 - CME/CMLE - Advances in I-O Biomarke ...
Image For Activity Cover
GROVIOEM2503 - CME/CMLE - Advances in I-O Biomarkers
Course Description

Advances in I-O Biomarkers 

Activity Description: 

This microlearning activity is designed to help pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in understanding advances in I-O biomarkers, in particular, PD-L1, MSI, and TMB. This activity focuses on evaluation methods and clinical significance of each of these biomarkers.  

Course topics include:  

  • Evaluation methods and the clinical significance of PD-L1 

  • Evaluation methods and the clinical significance of MSI 

  • Evaluation methods and the clinical significance of TMB 

The activity offers 0.25 CME/CMLE credit. 

Faculty/Authors

Yin P. Hung, M.D., Ph.D.  
Medical Director, Histology and Ancillary Diagnostic Laboratories 
Associate Professor of Pathology, Harvard Medical School 
Department of Pathology, Massachusetts General Hospital 
Boston, Massachusetts  

Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement

CME/CMLE Credit: 0.25
Estimated Completion Time: 0.25 hour
Format: Online educational activity

Target Audience 

This activity has been designed to meet the educational needs of pathologists and laboratory professionals.  

Credit Designation Statement

The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.   

ASCP designates this activity for a maximum of .25 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.   

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.  

Method of Participation

To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line.   

Commercial Support
This activity is supported by an independent educational grant from Bristol Myers Squibb.  



Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.
Faculty Disclosure


Technical Considerations 

Release Dates: 1/16/2025     
Review Date:
Expiration Date: 11/7/2027    




Course Objectives

Upon completion of this activity, you will be able to:

  • Identify the evaluation methods and the clinical significance of PD-L1 as a predictive marker in immuno-oncology 
  • Define MSI, its evaluation methods, and its clinical significance as a predictive marker in immuno-oncology 
  • Define TMB, its evaluation methods, and its clinical significance as a predictive marker of immuno-oncology 
Summary
Availability: On-Demand
Credit Offered:
0.25 CME/CMLE Credit
Powered By